In the aftermath of poor trading fundamentals, the price of global Norfloxacin API is expected to showcase a bearish trend throughout December 2022. Further, rising inflation and natural gas prices continue to hamper the downstream Demand for Norfloxacin API within the U.S. and Germany. Germany's profit margins remained at risk until now due to weak consumer sentiment and rising concerns about recession.

The suppliers in Europe (Germany) reduced the price of their goods marginally to eliminate their accumulating inventories by the end of 2022. Additionally, the downstream pharmaceutical industry's lower demand for Norfloxacin API could weaken the trade momentum, as orders in Germany have been declining by 2.24 percent since December 2022 and are expected to follow a similar trend.

In the U.S., a related market trend is envisioned for Norfloxacin API as the lack of downstream demand, ongoing economic unpredictability, and supply constraints intimidate the weaker market sentiments that already were and are likely to continue to showcase declining consumer sentiment of Norfloxacin API through the end of this year. Furthermore, the upcoming holidays on Christmas eve might result in the market's closure, owing to which stockpiling of inventories with the market participants is expected. According to a recent analysis, the prices of Norfloxacin API have declined by 2.94 percent to till date and are predicted to maintain a similar pattern until the first half of the new-year 2023.

According to ChemAnalyst, " the price of Norfloxacin API is likely to follow an upward trend in forthcoming months, i.e., in January 2023. However, Norfloxacin API markets might be on the upper side next month due to a significant rise in its downstream demand. To accommodate the spike in demand, market participants are anticipated to raise their stock levels along with them. On top of that, the trading momentum might improve further, which is likely to support the prices of Norfloxacin API in a positive direction.